Live Breaking News & Updates on Blood Therapeutics Chief Executive Ted Love

Stay updated with breaking news from Blood therapeutics chief executive ted love. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Pfizer agrees to $5.4B deal for Global Blood Therapeutics

The New York drugmaker is buying Global Blood Therapeutics, which sells a drug for sickle-cell disease and has two in development. It will pay $68.50 per share. ....

Albert Bourla , Pfizer Inc , Amgen Inc , Global Blood Therapeutics Inc , Chemocentryx Inc , Global Blood Therapeutics , Wall Street Journal , York Based Pfizer , Chief Executive Albert Bourla , South San Francisco , Blood Therapeutics Chief Executive Ted Love , Wall Street ,